Pediatric Neurosurgery

Case Report

Intracranial Germinoma Associated with Down’s Syndrome

Report of 2 Cases

Matsumura N. · Kurimoto M. · Endo S. · Fukuda O. · Takaku A.

Author affiliations

Department of Neurosurgery, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

Related Articles for ""

Pediatr Neurosurg 1998;29:199–202

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Published online: January 07, 1999
Issue release date: October 1998

Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE

Abstract

It is well known that Down’s syndrome is sometimes associated with leukemia. However, there have been only a few case reports of a relationship between Down’s syndrome and brain tumors. We report 2 cases with histological diagnoses of germinoma. The 1st case was a 10-year-old boy with Down’s syndrome complaining of seizure and left hemiparesis. Computed tomographic (CT) scan and magnetic resonance imaging (MRI) showed a mass lesion in the right basal ganglia and thalamus. Histological examination indicated two cell pattern germinomas. The 2nd case was a 20-year-old man with Down’s syndrome complaining of headache and vomiting. CT scan and MRI showed a pineal region tumor with marked hydrocephalus. Surgical specimens showed typical germinoma. Only 13 cases of brain tumors associated with Down’s syndrome have been reported. A higher incidence of germ cell tumors seems to be related to chromosomal abnormalities.




Related Articles:


References

  1. Miller RW: Neoplasia and Down’s syndrome. Ann NY Acad Sci 1970;171:637–644.
  2. Miller RW: Relation between cancer and congenital defects in man. N Engl J Med 1966;275:87–93.
    External Resources
  3. Zipursky A, Poon A, Doyle J: Leukemia in Down syndrome. Pediatr Hematol Oncol 1992;9:139–149.
  4. Shen JJ, Williams BJ, Zipursky A, Doyle J, Sherman SL, Jacobs PA, Shugar AL, Soukup SW, Hassold TJ: Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet 1995;56:915–925.
  5. Fujita T, Yamada K, Saitoh H, Itoh S, Nakai O: Intracranial germinoma and Down’s syndrome. Neurol Med Chir (Tokyo) 1992;32:163–165.
  6. Hokezu Y, Okada A, Kanehisa Y, Nagamatsu K, Matsunaga M: Down syndrome associated with radiosensitive brain tumor (in Japanese). Shinkei Naika 1987;26:86–89.
  7. Komiya K, Iwamoto H, Misugi K: A case of cerebellar tumor associated with Down’s syndrome (in Japanese). Senten Ijyo 1975;15:212–213.
  8. Nakato H, Kuwabara S, Maesako N, Inomata H, Ishimoto F, Hashida K, Kubota T: A case of Down’s syndorome complicated by teratoma of the third ventricle of the brain (in Japanese). No to Shinkei 1982;34:145–150.
    External Resources
  9. Oshita N, Yamashita K, Gotou K, Nagata I, Ueda H, Mitani T: A case of endodermal sinus tumor in the basal ganglia associated with Down’s syndrome (in Japanese). Neurol Surg 1993;21:345–349.
  10. Tanabe M, Mizushima M, Anno Y, Kondou S, Dejima S, Hirao J, Kamitani H, Watanabe T, Hori T: Intracranial germinoma with Down’s syndrome. A case report and review of the literature. Surg Neurol 1997;47:28–31.
  11. Wada H, Kubo M, Wada T, Ueno Y, Horita S, Ohki T, Munemoto S, Kuroda E, Taguchi H, Muramatsu N: A case of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen (in Japanese). No Shinkei Geka 1995;23:65–68.
  12. Yamasaki SA, Hamasaki Y: A infant case of a brain tumor associated with Down’s syndrome (in Japanese). Arch Jpn Chir 1985;54:305.
  13. Jennings M, Gelman R, Hochberg F: Intracranial germ-cell tumor. Natural history and pathogenesis. J Neurosurg 1985;63:155–167.
  14. Teilum G: Classification of endodermal sinus tumor (mesoblastoma vitellinum) and so-called ‘embryonal carcinoma’ of the ovary. Acta Pathol Microbiol Scand 1965;64:407–429.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Case Report

Published online: January 07, 1999
Issue release date: October 1998

Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP